- Home
- Publications
- Publication Search
- Publication Details
Title
Extramedullary Disease in Multiple Myeloma
Authors
Keywords
-
Journal
Current Hematologic Malignancy Reports
Volume 15, Issue 2, Pages 62-71
Publisher
Springer Science and Business Media LLC
Online
2020-03-20
DOI
10.1007/s11899-020-00568-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
- (2018) Marjorie Pick et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
- (2018) Nico Gagelmann et al. HAEMATOLOGICA
- Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
- (2018) Nico Gagelmann et al. HAEMATOLOGICA
- Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report
- (2018) Yanira Ruiz-Heredia et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Updated efficacy data and MRD analysis according to risk status in newly diagnosed myeloma patients treated with carfilzomib + lenalidomide or cyclophosphamide (FORTE trial).
- (2018) Francesca Maria Gay et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy for Relapsed Multiple Myeloma
- (2017) David Dingli et al. MAYO CLINIC PROCEEDINGS
- An unusual presentation of multiple myeloma with unilateral sudden vision loss
- (2017) Pei-Wen Wu et al. MEDICINE
- The possible role of burden of therapy on the risk of myeloma extramedullary spread
- (2016) Silvia Mangiacavalli et al. ANNALS OF HEMATOLOGY
- Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
- (2016) Saad Z. Usmani et al. BLOOD
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group
- (2016) P. Sonneveld et al. BLOOD
- Treatment of relapsed and refractory multiple myeloma
- (2016) Pieter Sonneveld et al. HAEMATOLOGICA
- Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation
- (2016) Ulrich J.M. Mey et al. HEMATOLOGICAL ONCOLOGY
- Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
- (2016) Valentina Marchica et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Treatment of relapsed and refractory multiple myeloma
- (2016) Pieter Sonneveld et al. HAEMATOLOGICA
- Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
- (2015) Eirini Katodritou et al. ANNALS OF HEMATOLOGY
- Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study
- (2015) Eli Muchtar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations
- (2015) Cindy Varga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Features of Extramedullary Disease of Multiple Myeloma: High Frequency of P53 Deletion and Poor Survival: A Retrospective Single-Center Study of 834 Cases
- (2015) Shuhui Deng et al. Clinical Lymphoma Myeloma & Leukemia
- Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement
- (2015) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma
- (2015) L Vincent et al. Blood Cancer Journal
- CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
- (2015) Aldo M. Roccaro et al. Cell Reports
- Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center Series
- (2014) Eli Muchtar et al. ACTA HAEMATOLOGICA
- Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma
- (2014) Sung-Eun Lee et al. ANNALS OF HEMATOLOGY
- MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression
- (2014) Shih-Feng Cho et al. BMC CANCER
- Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal
- (2014) Jiajia Zhang et al. HEMATOLOGICAL ONCOLOGY
- Cytogenetics of extramedullary manifestations in multiple myeloma
- (2013) Lisa Billecke et al. BRITISH JOURNAL OF HAEMATOLOGY
- Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents
- (2013) Christine I. Chen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
- (2013) L. Pour et al. HAEMATOLOGICA
- Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases
- (2012) Leo Rasche et al. ANNALS OF HEMATOLOGY
- Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
- (2012) L. Rosinol et al. BLOOD
- FDG PET or PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma
- (2012) Yu-Yu Lu et al. CLINICAL NUCLEAR MEDICINE
- Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents
- (2012) S. Z. Usmani et al. HAEMATOLOGICA
- Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach
- (2011) Joan Bladé et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy and the activity of pomalidomide on extramedullary myeloma
- (2011) K Detweiler Short et al. LEUKEMIA
- Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
- (2011) Heather Landau et al. LEUKEMIA & LYMPHOMA
- Successful Treatment of Extramedullary Tumors with Low-dose Thalidomide in Patients with Multiple Myeloma
- (2010) Hajime Yasuda et al. INTERNAL MEDICINE
- Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
- (2009) M. Varettoni et al. ANNALS OF ONCOLOGY
- The impact of extramedullary disease at presentation on the outcome of myeloma
- (2009) Ping Wu et al. LEUKEMIA & LYMPHOMA
- p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma
- (2009) Neil Sheth et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search